A study showed that the ablation of caspase-8 protected against hepatic steatosis, accumulation of ROS, apoptosis, liver inflammation, and fibrosis in NASH mice (Hatting et al., 2013). Here, CASP8 is linked to metabolic dysfunction-associated steatohepatitis.